The rheumatoid arthritis drugs industry grows at 6.8% CAGR to US$56.62 billion by 2033, propelled by PET/MRI diagnostics and awareness campaigns. Learn about North America's dominance, emerging market surges, and global shifts toward effective, accessible RA management. https://au.finance.yahoo.com/news/rheumatoid-arthritis-drugs-market-size-155000726.html